By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…
Month: April 2026
Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout
By Mariam Sunny April 6 (Reuters) – Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash,…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…
Logan sketches path to shrink size of Fed balance sheet
By Michael S. Derby April 2 (Reuters) – Dallas Federal Reserve President Lorie Logan on Thursday laid out paths and…